Published in Diabet Med on July 01, 1994
Gestational diabetes mellitus is associated with TCF7L2 gene polymorphisms independent of HLA-DQB1*0602 genotypes and islet cell autoantibodies. Diabet Med (2011) 0.87
A community-based survey for different abnormal glucose metabolism among pregnant women in a random household study (SAUDI-DM). BMJ Open (2014) 0.82
Epigenome-wide and transcriptome-wide analyses reveal gestational diabetes is associated with alterations in the human leukocyte antigen complex. Clin Epigenetics (2015) 0.82
Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report. Reprod Biol Endocrinol (2008) 0.78
Postpartum development of type 1 diabetes in Asian Indian women with gestational diabetes. Indian J Endocrinol Metab (2016) 0.75
Immune responses to glutamic acid decarboxylase and insulin in patients with gestational diabetes. Clin Exp Immunol (2004) 0.75
Gestational diabetes and thyroid autoimmunity. Int J Endocrinol (2012) 0.75
Prevention of type 2 diabetes mellitus in women with previous gestational diabetes mellitus. Korean J Intern Med (2017) 0.75
Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet (1983) 5.64
Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet (1974) 5.59
In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med (1985) 4.65
HL-A antigens and diabetes mellitus. Lancet (1974) 4.42
HL-A antigens and disease. Statistical and genetical considerations. Tissue Antigens (1974) 4.41
HLA and disease 1982--a survey. Immunol Rev (1983) 3.87
Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet (1983) 3.85
Type 1 (insulin-dependent) diabetes and a highly variable locus close to the insulin gene on chromosome 11. Diabetologia (1985) 3.65
Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol (1995) 3.30
A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet (2001) 3.26
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
Interferon-gamma induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol (1985) 3.18
Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature (1985) 3.11
HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature (1987) 2.96
HL-A and disease associations--a survey. Transplant Rev (1975) 2.87
A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet (1999) 2.85
Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci U S A (1999) 2.83
Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group. Lancet (1997) 2.70
Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol (1990) 2.67
Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum (1999) 2.66
Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes (1997) 2.65
The selection of control subjects for case/control analysis of susceptibility to type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1993) 2.63
Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet (1982) 2.43
Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature (1997) 2.41
Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet (1973) 2.41
Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet (1984) 2.38
TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity (1999) 2.33
Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet (1995) 2.31
A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics (1994) 2.31
Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science (1985) 2.27
Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest (1999) 2.24
Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol (1998) 2.11
HL-A antigens and multiple sclerosis. Lancet (1972) 2.09
Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol (1976) 2.08
Genetic and immunologic factors in microvascular disease in type I insulin-dependent diabetes. Diabetes (1982) 2.05
Presence of the organ-specific 'microsomal' autoantigen on the surface of human thyroid cells in culture: its involvement in complement-mediated cytotoxicity. Clin Exp Immunol (1981) 2.04
No risk of diabetes after insulin-shock treatment. Lancet (1992) 2.02
Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia (2008) 2.01
Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage. Lancet (1980) 2.00
T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics. Immunity (1999) 1.98
MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease. Transplant Rev (1975) 1.97
Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer. N Engl J Med (1993) 1.95
Autoantibodies to prolactin-secreting cells of human pituitary. Lancet (1975) 1.92
Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet (1997) 1.92
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk. Diabetes Metab Res Rev (2002) 1.85
Organ-specific autoimmunity: a 1986 overview. Immunol Rev (1986) 1.84
Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia (2012) 1.83
Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med (2000) 1.83
Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum (1982) 1.83
Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes (1994) 1.82
Pancreatic somatostatinoma. Clinical features and physiological implications. Lancet (1977) 1.81
BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation. Anal Biochem (1999) 1.81
HLA genotype distribution and genetic models of insulin-dependent diabetes mellitus. Ann Hum Genet (1981) 1.78
Gluten-free diet prevents diabetes in NOD mice. Diabetes Metab Res Rev (1999) 1.77
Predicting insulin-dependent diabetes. Lancet (1988) 1.75
Genetics of HLA disease association. Annu Rev Genet (1981) 1.74
Significant decrease in congenital malformations in newborn infants of an unselected population of diabetic women. Am J Obstet Gynecol (1989) 1.71
Human cell-mediated cytotoxicity against modified target cells is restricted by HLA. Nature (1977) 1.69
Evidence for an association between rheumatoid arthritis and autoimmune endocrine disease. Ann Rheum Dis (1983) 1.64
Studies of the HLA system and insulin-dependent diabetes mellitus. Diabetes Care (1980) 1.63
Adrenaline stimulates glucagon secretion in pancreatic A-cells by increasing the Ca2+ current and the number of granules close to the L-type Ca2+ channels. J Gen Physiol (1997) 1.62
Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet (1998) 1.62
The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain. J Biol Chem (2001) 1.59
From the fetal liver to spleen and gut: the highway to natural antibody. Mucosal Immunol (2009) 1.59
Subclinical coeliac disease in schoolchildren from northern Sardinia. Lancet (1999) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
Protracted diarrhoea of infancy: evidence in support of an autoimmune variant. Br Med J (Clin Res Ed) (1986) 1.55
Evidence for a primary autoimmune type of diabetes mellitus. Br Med J (1978) 1.55
Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet (1990) 1.54
CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol (1998) 1.50
Dual role of mannan-binding protein in infections: another case of heterosis? Eur J Immunogenet (1994) 1.50
Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens (2004) 1.47
Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc Natl Acad Sci U S A (1997) 1.47
Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol (2001) 1.47
The HL-A7 histocompatibility antigen in sarcoidosis in relation to tuberculin sensitivity. Tissue Antigens (1975) 1.45
A family study of the association between insulin dependent diabetes mellitus, autoantibodies and the HLA system. Tissue Antigens (1984) 1.44
HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus. Diabetologia (1981) 1.43
A short element required for turning off heat shock transcription factor: evidence that phosphorylation enhances deactivation. EMBO J (1994) 1.43
Autoantibodies to cartilage and type II collagen in relapsing polychondritis and other rheumatic diseases. Ann Rheum Dis (1981) 1.42
Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol (1988) 1.40
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40
[Transplantation. Blood, bone marrow and solid organs]. Ugeskr Laeger (2000) 1.39
Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci U S A (1998) 1.38
Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation (1992) 1.38
Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol (1992) 1.38
The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis Rheum (2000) 1.37
Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol (1988) 1.37
HLA--Dw4 and rheumatoid arthritis. Tissue Antigens (1979) 1.36
Goitrous autoimmune thyroiditis (Hashimoto's disease). Clin Endocrinol Metab (1979) 1.36
Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J Exp Med (1996) 1.36